Mylan Pharmaceuticals Inc. et al. vs. Bausch Health Ireland Limited et al.
Explore the PTAB proceeding IPR2022-00722 filed by Mylan Pharmaceuticals Inc. et al. on 2022-03-21. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2022-00722
Filing Date
2022-03-21
Accorded Filing Date
2022-03-21
Institution Decision Date
2022-09-14
Last Modified Date
2026-03-31
Proceeding Type
IPR
Termination Date
2026-01-27
Trial Status
Final Written Decision - Appealed
Parties & Counsel
Petitioner
Mylan Pharmaceuticals Inc. et al.
Represented By
Mills, Jadet alPatent Owner / Respondent
Bausch Health Ireland Limited et al.
Represented By
Hasford, Justinet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
5 Total
Proceeding Status
Final Written Decision - Appealed
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (5)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 32942 | Mark Simpson | +1 215-972-7880 |
| 36317 | Kathryn Doyle | +1 215-972-7734 |
| 36358 | Gianna Julian-Arnold | +1 410-332-8913 |
| 41472 | Darius Gambino | +1 215-972-7173 |
| 52441 | Peter Brunovskis | +1 202-662-2782 |
| 56969 | Daniel Kopp | +1 202-344-4600 |
| 60882 | Alireza Behrooz | +1 202-295-6687 |
| 62074 | Brian Landry | +1 617-912-0969 |
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 12 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 7,041,786 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 7,799,897 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,114,831 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,637,451 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2014012116 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2020032517 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 27,943,701 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 27,943,801 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 30,085,001 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 30,380,601 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 30,735,801 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 34,864,602 P | US Continuation / Sibling | View Official Patent → |
MSN Laboratories Private Ltd. et al. v. Bausch Health Ireland Limited et al.